News
With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the US EoE market ...
Basilea has acquired the global rights for Venatorx Pharmaceuticals’ ceftibuten-ledaborbactam etzadroxil, an antibiotic being ...
Apertura Gene Therapy has entered several licensing agreements to advance CNS treatments using its TfR1 CapX technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback